How AI is Revolutionizing Precision Medicine: Dr. Douglas Flora & Dr. Sanjay Juneja on the Future of Cancer Care
In this episode of the Precision Medicine Podcast, host Karan Cushman engages in a thought-provoking discussion with two pioneers in AI-driven oncology: Dr. Douglas Flora and Dr. Sanjay Juneja. Together, they explore how AI is revolutionizing cancer care, from earlier detection and faster diagnoses to personalized treatments and clinical trial optimization.
Interested in sponsoring
the Podcast?
Contact Karan Cushman, Executive Producer, for programming details.
AI’s potential in oncology is game-changing. Dr. Flora and Dr. Juneja break down how AI is helping to identify cancer at its earliest, most treatable stages, automate biomarker testing, and streamline clinical trials to match patients with the best therapies faster than ever before. AI is not just a futuristic concept—it is already helping oncologists reduce misdiagnoses, improve screening accuracy, and speed up treatment approvals, all of which could significantly improve patient outcomes.
But if AI is so transformative, why isn’t it more widely used? Adoption remains one of the biggest hurdles, with challenges ranging from regulatory barriers and insurance limitations to the slow integration of AI into clinical practice. Karan challenges her guests to explain what needs to change for AI-driven precision medicine to reach more patients—sooner rather than later.
With her patient-first perspective, Karan ensures the conversation stays focused on what these advancements mean for real people. Looking ahead to 2030, the discussion explores what a fully AI-integrated oncology system could look like—and why the revolution in cancer care isn’t coming—it’s already here.
Dr. Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, and Dr. Sanjay Juneja is a hematologist-oncologist, social media educator, and VP of Clinical AI Operations at Tempus AI. Both guests are co-founders of Tensor Black, an education and consulting company specializing in AI applications in oncology.
​
Download the full transcript of the episode here (pdf).
Like what you hear? Please spread the joy...
-
Share the Precision Medicine Podcast with your friends
-
Leave a review and subscribe in your favorite podcast app!
-
Follow us on Twitter @PMPbyTrapelo
-
Follow us on Linked In
Interested in sponsoring the Precision Medicine Podcast?
Simply email our host Karan Cushman.
​
Don't miss the next episode...
About Our Guests
​​​Douglas Flora, MD, FACCC, LSSBB
Hematologist & Medical Oncologist
Dr. Douglas Flora is the Executive Medical Director of Oncology Services, and The Robert and Dell Ann Sathe Endowed Chair in Oncology at the St. Elizabeth Healthcare Cancer Center headquartered in Edgewood, Kentucky.
Dr. Flora graduated from The Ohio State University College of Medicine in 1999. With a distinguished career spanning over two decades, he is a steadfast advocate for whole-person care and medical innovation. His leadership and vision have led to cutting-edge technology and treatment protocols and improved patient outcomes.
As the Editor-In-Chief for the pioneering peer-reviewed research journal AI in Precision Oncology, Dr. Flora plays a pivotal role in medical education and research, nurturing the next generation of healthcare leaders. His perspective is enriched by personal experience as a practicing oncologist, senior healthcare executive, and most importantly, a cancer survivor.
In addition to being a co-founder of TensorBlack, an education and consulting company specializing in AI applications in oncology, Dr. Flora is a Board Member of the American Cancer Society. He also serves on the Executive Board of the Association of Community Cancer Centers as Treasurer, and is a Board Member of the Kentucky Society of Clinical Oncology.
Sanjay Juneja, M.D.
Hematologist & Medical Oncologist
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine. Garnering over 750k followers and 20 million views on social media, Dr. Juneja’s unique ability to simplify complex topics has earned him global acclaim. His debut podcast, Target Cancer: Podcast, amassed over 2 million downloads in more than 100 countries within just two years, setting the stage for his current AI-focused series featuring world-renowned guests. He now co-hosts the AI and Healthcare podcast.
Dr. Juneja’s accolades include being named Targeted Oncology’s inaugural 2024 Oncology Icon, an invitation to the White House’s 2023 Healthcare Leaders in Social Media Roundtable, and recognition as a 40 Under 40 honoree and one of the Capital Region’s Top 500 Most Influential Leaders for three consecutive years. His insights have been featured in The Washington Post, WIRED, Bloomberg, and PBS.
In addition to co-founding TensorBlack, an education and consulting company specializing in AI applications in oncology, Dr. Juneja serves as Vice President of Clinical AI Operations at Tempus AI. He is also an Editorial Board Member for the peer-reviewed journal AI in Precision Oncology.